Rx lobby prepares to launch multimillion-dollar ad campaign to fix PR problems

November 18, 2016

VoicesInStreamPhotoFollowing consumer and congressional outrage about huge price increases for the EpiPen, the pharmaceutical industry is gearing up for a fight.

Pharmaceutical Research and Manufacturers of America (PhRMA), which represents large drug companies, is bracing for a post-election battle over prices.

Politico has learned the trade group is requiring member companies to pay an additional $100 million per year in dues.

The decision to raise membership dues by 50 percent means the pharmaceutical lobby will have more than $300 million a year to spend on advertising. PhRMA hopes the massive PR campaign will improve its public image and fend off any legislative action.

The group plans to run new TV advertising showing how new drugs could add years to patients’ lives. Ads will also highlight the complex research needed to develop a new drug – spending that must then be recovered through high prices.

PhRMA has consistently ranked among the largest lobbying spenders in Washington the past few years. The trade group has spent $11.8 million so far in 2016, making it the fourth-largest lobbying powerhouse, according to Politico’s report.

Are you affected by skyrocketing prescription prices? Please share your story and any tips you may have with Voices for Affordable Health. https://voicesforaffordablehealth.com/share-your-voice/.